Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid

Area of Science:

• Biochemistry
• Immunology
• Rheumatology

Background:

• The fibrinolytic system regulates blood clot breakdown.
• Its role in inflammatory joint diseases is not fully understood.
• Alpha 2-plasmin inhibitor-plasmin complexes indicate fibrinolytic system activity.

Purpose of the Study:

• To investigate the presence and levels of alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid (SF) from patients with various inflammatory joint diseases.
• To determine if the plasminogen system is active in inflammatory SF.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to quantify alpha 2-plasmin inhibitor-plasmin complexes.
• Synovial fluid samples were collected from patients with different types of arthritis.

Main Results:

• Alpha 2-plasmin inhibitor-plasmin complexes were detected in both rheumatoid and non-rheumatoid SF.
• The highest concentrations of these complexes were observed in SF from patients with septic arthritis.
• These findings indicate an intact plasminogen system in inflammatory SF.

Conclusions:

• The plasminogen system is active in inflammatory synovial fluid.
• Plasmin, a key enzyme in fibrinolysis, likely contributes to the local inflammatory processes in joint diseases.
• Septic arthritis shows the most significant activation of this system.